- Home
- SSII vs TSHA Comparison
SSII vs TSHA Comparison
Compare SSII & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSII
- TSHA
- Stock Information
- Founded
- SSII N/A
- TSHA 2019
- Country
- SSII India
- TSHA United States
- Employees
- SSII N/A
- TSHA N/A
- Industry
- SSII
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- SSII
- TSHA Health Care
- Exchange
- SSII Nasdaq
- TSHA Nasdaq
- Market Cap
- SSII 1.4B
- TSHA 1.4B
- IPO Year
- SSII N/A
- TSHA 2020
- Fundamental
- Price
- SSII $8.54
- TSHA $4.93
- Analyst Decision
- SSII
- TSHA Strong Buy
- Analyst Count
- SSII 0
- TSHA 9
- Target Price
- SSII N/A
- TSHA $10.00
- AVG Volume (30 Days)
- SSII 166.0K
- TSHA 11.7M
- Earning Date
- SSII 11-14-2025
- TSHA 11-12-2025
- Dividend Yield
- SSII N/A
- TSHA N/A
- EPS Growth
- SSII N/A
- TSHA N/A
- EPS
- SSII N/A
- TSHA N/A
- Revenue
- SSII $27,623,624.00
- TSHA $8,098,000.00
- Revenue This Year
- SSII N/A
- TSHA N/A
- Revenue Next Year
- SSII N/A
- TSHA N/A
- P/E Ratio
- SSII N/A
- TSHA N/A
- Revenue Growth
- SSII 134.89
- TSHA N/A
- 52 Week Low
- SSII $2.48
- TSHA $1.05
- 52 Week High
- SSII $22.42
- TSHA $5.51
- Technical
- Relative Strength Index (RSI)
- SSII 55.57
- TSHA 59.67
- Support Level
- SSII $8.25
- TSHA $4.70
- Resistance Level
- SSII $10.00
- TSHA $5.33
- Average True Range (ATR)
- SSII 0.92
- TSHA 0.36
- MACD
- SSII -0.02
- TSHA -0.07
- Stochastic Oscillator
- SSII 59.44
- TSHA 45.91
About SSII SS Innovations International Inc.
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.